dhea therapy postmenopausal women move forward lack evidence pubmed ncbi abstract marked age-related decline serum dehydroepiandrosterone dhea dehydroepiandrosterone sulfate dheas suggested deficiency steroids causally related development series diseases generally aging postulated consequences low dhea levels include insulin resistance obesity cardiovascular disease cancer reduction immune defence system psychosocial problems depression general deterioration sensation well-being cognitive function clinically spectrum women benefit dhea therapy defined dosage hormone treatment dhea therapy prescribed general anti-aging therapy alternative treatment women suffering androgen deficiency syndrome remains uncertain studies lack definitive evidence biological mechanisms presence studies address emerging issues dhea therapy postmenopausal women encourage critical analysis literature evidencing current limits incongruities 
